In the present perspective it is described the advances and real possibilities of 1,3-dipolar cycloadditions as key step in the total synthesis of virus inhibitors. Azides, nitrones, and azomethine ylides are the most appropriate 1,3-dipoles for the synthesis of privileged structures 10 with the highest biological response against viruses.
Introduction
Newly emerging viral infections represent the major threat to human health. If we analyze the data concerning only the killed people by the Influenza pandemics during the last 15 century, we notice that this number goes beyond the deaths caused by other natural or man-made disasters. World Human Organisation (WHO) 1 alerts on the viral outbreaks announcing the spreading ways of the virus urging all governments to step up surveillance.
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Apart of the three more extended global virus infections namely human immunodeficiency virus (HIV, 35 millions approximately), hepatitis C virus (HCV, more than 190 millions) and influenza A and B viruses, ebola, Marburg, dengue, yellow fever, nipah, enterovirus 71 and oncoviruses 25 are the most dangerous viruses causing many human fatalities. 2 An additional drawback of these microorganisms is their fast mutation rates because a small genetic variation in an, a priori, inoffensive virus can originate a new strand with increased capacity to cause disease (virus with increased 30 virulence). The vaccine development is an extremely effective strategy to protect people from specific virus infections. However, an appropriate vaccine cannot be developed before a virus can be replicated in sufficient quantities to manufacture it. In fact, 35 vaccines are very effective on stable virus but difficult to apply to rapidly mutagenic viruses such as influenza, HCV, etc. In this last situation, and obviously when the patient has already been infected, is when antiviral drugs became crucial. An antiviral drug does not kill the virus, but acts by 40 interfering one step of the viral replication process. This lowering in the replication frequency allows the body's immune system to destroy the virus using many natural defences.
Researchers working on strategies for developing antivirals 45 have tried to attack viruses at every stage of their life cycles, namely attachment to a host cell, replication of viral components, assembly of viral components into complete viral particles and release of viral particles able to infect new hosts cells. The present and the future of these antiviral tools has 50 been reported since the pharmacological point of view of pathogenic specific drugs such as amantidine, Tamiflu ® , and Relenza ® or ribavirin and interferons targeted against influenza or hepatitis C viruses, respectively. 3 Unfortunately, extensive data on their efficacy are not available and recent 55 reports of drug resistance in patients infected with, for example, H5N1 raise serious concerns. 4 So, new broadspectrum antivirals must be developed because the cost and the risk to a rapid drug resistance of the antivirals targeted against single viruses are very elevated. 60 Genomics helps scientists to find targets at every viral stage and also provides crucial data for understanding the drugvirus effective interaction. Closely, the organic synthetic chemists are dedicating many efforts to design and prepare potential drugs once targets have been identified. From all of the resources, methodologies, reactions, etc., put into service of the preparation of antiviral agents, 5 1,3-dipolar cycloaddition (Hüisgen cycloadditions) 6 constitute a powerful classical synthetic tool and one of the most productive fields in modern organic chemistry.
7 70 The reaction between 1,3-dipoles and alkenes or alkynes is very versatile allowing the presence of many functional groups in both components, namely 1,3-dipole I and dipolarophile II (Scheme 1). Yields of heterocycles III are elevated with a few and easily removable impurities. The 75 available precursors of dipole I can be, basically, divided in two groups: the allyl anion-type Ia such as nitrones, azomethine ylides, azomethine imines, carbonyl ylides and carbonyl imines, and the linear propargyl/allenyl anion-type Ib such as nitrile oxides, nitrile imines, nitrile ylides, This [2s+4s] addition is stereoconservative (suprafacial) and stereospecific, and the six π-electrons participate in a concerted or non-concerted reaction pathway controlled by the 5 HOMO-LUMO interaction rules.
7c, 8 The results of this elevated stereocontrol is the responsible of the high diastereo and regioselectivity (and also enantioselectivity in asymmetric synthesis examples) achieved in an impressive number of heterocycles III. 7, 9 Another important feature of this 10 transformation 10, 11 is that up to four stereogenic centres can be unambiguously generated in only one reaction step whether a diastereo-or enantioselective approach is performed. The general interest of these broad series of cycloadducts III, as potential antiviral drugs, 12 will be focussed on this 15 perspective. For convenience, the examples will be classified on the basis of the involved 1,3-dipole, which are highlighted in a frame in the Figure 1 . drugs compatible with the side chain of all of the amino acids and the molecular dimensions of these heterocycles are somewhat similar to the amide bonds in terms of distance and planarity. These last two properties of 3 are closely related with the successful interaction with enzymes or even DNA or 50 RNA strands of the viruses in order to deter their proliferation. There is not vaccine or cure for HIV, and the most employed treatment consists of highly active antiretroviral therapy. Many derived compounds of AZT (a reverse transcriptase inhibitor) and others were prepared through a 1,3-DC between organic azides and alkynes with the objective of decreasing the viral replication and lowering their cytotoxicity ( Figure 2 ). Nucleosidic molecules 5-7 and 9, and the non-nucleosidic structures 8 and 10 are examples of triazole-containing entities able to inhibit HIV proliferation. 70 One of the first contributions in this area was published in 1989, but nucleoside 5 showed moderate activity in HIV-1 infected cells. 17 The same author used hydrazoic acid as 1,3-dipole and a carbodiimide as dipolarophile, generated from AZT, for the elaboration of compound 6, which also exhibited 75 moderate activity against HIV-1. 18 The series of products 7
Azides
were prepared and tested as antiviral HIV agents, the most active being R 1 = Bu t (Me) 2 Si-, R 2 , R 4 = H, R 3 = CONMe 2 .
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Phosphasugar N-nucleoside derivatives were prepared to be antiviral agents but any data about biomedical studies was 80 described. 20 Compound 9 showed an interesting activity against wild type HIV-1 and mutant strains, which is comparable with other nucleoside reverse transcriptase inhibitors such as MKC-442. 21 Molecules 5-9, as surrogates of AZT, function as analogues for thymidine and this means that 85 AZT and its mimetics, have the same shape as it, and therefore it can be incorporated into the developing nucleic acid in place of a thymidine molecule. 
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A recent contribution demonstrated that compound 10 retains high affinity for both wild-type and PR 6x multidrug resistant (MDR) protease viruses as the result of interactions with selected residues and maintenance of hydrogen bonding to main chain 35 atoms. Thus, compound 10 binds to the protease that promotes multidrug resistance, the triazole moiety forms a precise hydrogen bonding network and the carbamate accepts a hydrogen bond from the amide of Gly48. Both of these interactions feature a conserved element of protease structure. The 1,3-DC of 5 modified starters 11 and 12 will also allow the evaluation of whether such changes improved the antiviral performance against newly appearing multidrug-resistant viruses. 24 The employment of the catalysed 1, 3 strains of HIV-1 in a peripheral blood mononuclear cell-based assay and inhibits syncytium formation in the AA-2 cell line. Worldwide extended influenza viruses caused seasonal epidemic. Vaccinations against influenza are usually given to people, the most common being trivalent influence vaccine 30 (TIV). It contains purified and inactivated material for two influenza A viruses subtype and one influenza B strain. Spite of this advantage, several specific antiviral drugs have been designed to inhibit the most aggressive influenza virus types. The most active synthetic compound corresponded to the series of 35 non-nucleosidic molecules 13, whose structure is very similar to zanamivir. In fact, compound 13 [R 1 = CH(OH)C 2 H 5 , R 2 = H) is almost as active as zanamivir against avian influenza virus (AIV) H5N1. 27 In this work molecular modelling provided very reliable information about the binding model between inhibitors and 40 neuraminidase, which was in a good agreement with the observed in vivo activity of the inhibitors. To better understand the activity discrepancy of synthesised new inhibitors and zanamivir, the study was based on the crystal structure of neuraminidaseinhibitors derived from docking simulation. Whilst carboxylic 45 acid group of zanamivir formed strong hydrogen bonds with two arginine residues (Arg118, Arg371) in the S1 region and five hydrogen bond interactions in S2 region through the guanidinyl moiety, inhibitor
forming exclusively a hydrogen bond with residue Arg152 in the 50 S2 region. Large substituents with different electronic properties of other molecules 13 could not be accommodated in the subsite S2, and hence the six membered ring flipped resulting in a drop of inhibitory activity. There is currently substantial interest in the use of nucleic acids for modifying gene expression for therapeutic purposes. The lipid-conjugated oligonucleotides via 1,3-DC potentiates 90 the cellular uptake of oligonucleotides and allows their intracellular delivery. These non-toxic lipid conjugates 18 ( Figure 4 ) efficiently inhibit HCV internal ribosome entry site-mediated translation in human hepatic cells. The specific target was the subdomain IIId of the mentioned internal 95 ribosome entry site at the 5' end of the viral RNA. Acyclonucleosides 22 and 23, with the alkylating chain of acyclovir, were prepared and evaluated against tuberculosis virus showing moderate activity. 35, 36 Carbonucleosides 24 gave very low inhibition levels of small pox, vaccinia or cowpox viruses. 37 However, 1,2,3-triazole carbanucleosides 30 25 and more specifically iodide 26 ( Figure 6 ) exhibited an elevated inhibitory potential against thymidine kynase varicella-zoster virus (TK + VZV). 38 Another applications of 1,3-DC of azides and alkynes or alkenes concerns the construction of biomolecular prototypes. 35 For example, it was observed that the degradation of the viral particles occurred during the 1,3-DC of the corresponding alkyne, and the azide derived from the icosahedral cowpea mosaic virus (CPMV). Molecules 27 ( Figure 6 ) incorporate an aliphatic chain with a 1,2,3-triazol unit. This carbonous 40 structure is bonded to the virus through an amino group of the native reactive lysines, and genetically inserted cysteines of the protein subunits arranged helically around genomic single RNA strand. 39 This binding caused degradation or variation of the stability of the viral peptides, which has been considered 45 of great interest for future investigations. Although they are not considered antiviral agents, there are another contributions dealing with the synthesis of very interesting useful molecules for the study of biomolecular recognition, binding mecanisms, etc. For example, the 55 synthesis of radiolabelled peptides ( 18 F or 11 C), incorporating 1,2,3-triazole units, have been used as diagnostic agents, for example, as radiopharmaceuticals for several purposes, and also served as a vector to direct a small drug to the virus. 42 As well, azides and alkynes are easily transformed in the 60 corresponding 1,2,3-triazoles in the synthesis of ligands for the preparation of antiviral drugs, 43 in the preparation of sensors on oligo-or poly(ethylene glycol) films on silicon surfaces, which possessed an structural portion capable of being recognised by a biological specimen (included viruses), 44 and finally, in the elaboration of cross-linked polymeric multilayers, interesting for the fields of directed drug delivery towards viruses and tissue engineering. 
Nitrones
Nitrones 28 or azomethine oxides were first prepared by Beckman in 1890. Their chemistry is hugely varied, 46 but it is 10 ultimately dominated by their use as 1,3-dipoles for cycloaddition reactions. 7, 47 The most common 1,3-DC involving nitrones, is the formation of isoxazolidines 30 48 using alkenes 29 as dipolarophiles (Scheme 5), although other different multiply bonded systems may also be used such as 15 alkynes, allenes, isocyanates, nitriles, thiocarbonyls, etc. The isoxazolidine adduct 30 contains up to three new stereogenic centres and the reaction products can be predictable according to the experiences, results and frontier molecular orbital (FMO) theory.
7c The E/Z-interconverting nitrones 28 reacted 20 with electron-rich alkenes 29a through a first nitrone oxygen atom attack to the α-position of the electron-rich alkene, however, this oxygen atom react with the β-position of the electron-poor alkenes 29b (Scheme 5). Often, diastereomeric pairs of exo-and endo-adducts are formed under thermal 25 conditions. However, steric hindrance is of importance to control the approach of the alkenes towards the nitrones. Operating under metal-catalysed or organocatalysed processes, run at lower temperatures, the overall control of the absolute configuration of each stereogenic centre can be 30 achieved. The diastereoselective processes are also efficient to furnish optically enriched heterocycles. This cycloaddition has been applied (in lesser extension than the above mentioned azides) to the elaboration of inhibitors of RNA viral strands. For example, it was found that derivatives of natural nucleic acids play an important role 40 in current chemotherapy as potent and selective antiviral agents in AIDS treatment. The ribose ring surrogates depicted on Figure 7 are considered as active inhibitors of HIV. Especially active was product ADF 37, which was a good inducer of cell death by apoptosis on Molt-3-cells, a 45 continuous line of human thymphoblasts. 49 In previous works some isoxazolidines 31-35 (also called azadideoxynucleosides) were synthesized through the same route with identical objective, but the inhibition of HIV was only moderate. 50, 51, 52, 53 In all cases, products 31-37 were obtained replication in the range of 100 μM. The particular conformation of 39 reduces the probability of puckering interconversion, which justify strongly the conserved DNAlike shape and therefore they could be considered for optimisation studies for designing more potent HCV reverse 75 transcriptase inhibitors. 55 Phosphonated carboxylic-2'-oxa-3'-azanucleosides 40 were obtained according to the already mentioned thermal 1,3-DC. The nitrone-phosphonate and vinyl acetate followed by the attack of the purine or pyrimidine moiety to the anomeric carbon. The resulting 80 nucleosidic derivatives 40 were tested and low levels of cytotoxicity were detected, but most importantly was their activity as inhibitors of reverse transcriptase in virus. In fact, it was as powerful as AZT and one of the most effective known inhibitors of the hepatitis B virus. 56 The ability of the 85 newly synthesized compounds to inhibit retroviral RNAdependent DNA polymerase (reverse transcriptase) activity was determined by means of a novel, cell-free assay, originally developed for a preliminary screening of potential inhibitors of reverse transcriptase. In this assay, RNA isolated 5 from stable transfectants, expressing constitutively the glycoprotein D (gD) of HSV-1, was used as template for the reversal transcriptase activity of commercial avian myeloblastosis virus reverse transcriptase (AMV-RT) and moloney murine leukemia virus reverse transcriptase (MLV-10 RT). 56 The postulated mechanism of the inhibition of the reverse transcriptase was identical to the already described for AZT surrogates (above).
The homologous series of azanucleosides 41 were prepared by the same chemical route but using a microwave radiation 15 (100 W, 20 min) for the obtention of a 1.8:1 endo:exo ratio of the precursor isoxazoline in 65% yield. Their activity as inhibitors of HIV or HBV was moderate and lower than homologous structures 40. However, compounds 41 contributed to the research of the structural features, which 20 concur to determine the biological activity of the N,Onucleoside system.
The insertion of nucleotides in the growing nucleic acid chain, operated by polymerases, is assisted by bivalent metallic ions that facilitate the transfer of nucleotide units. It 25 was speculated that the nitrogen atom of the heterocycle would facilitate the breaking between P α and P β in the nucleotide triphosphate structure and, in this way, allows the transfer of a diphosphoryl or a nucleotidyl group. The nitrogen atom is probably responsible for metal-ion 30 coordinations and, in this context, while the distance P α -N 3 in compounds 40 promotes the formation of 6-membered chelates, for compounds 41 the distance P α -N 3 is not compatible with anyone stable 7-membered chelate and, consequently, any antiviral activity is forbidden. 57 35 Compound 42, obtained by reaction of the corresponding nitrone and allyl alcohol at 160 ºC, was active against the bunyavirus punta toro virus (PTV) for which cytotoxic/antiviral ratio was virtually 10-fold. This PTV is one of eight members of the family Bunyaviridae, which 40 produce disease in man through accelerated apoptosis of hepatocytes in vivo. Preliminary docking studies of this compound 42 to the B-DNA fragment d(CGCAATTGCG) 2 show that it preferentially intercalates in the DNA AT region, and the resulting complex is further stabilised by a hydrogen 45 bond between the hydroxyl group of the hydroxymethyl moiety and an oxygen of a phosphate group. 58 Whilst potentially inhibitors of virus endo-and exo-43 are currently being evaluated in vivo, 59 the formation of isoxazole 44 was the key step in the total synthesis of racemic BCX-50 1812(RWJ-270201) 45. The 1,3-DC was performed at room temperature in the presence of sodium hypochlorite with an isolated yield of 61%. Compound 45 is in clinical phase due to its notable selectivity and potency against neuraminidase of a wide range of influenza A and B viruses. The strong 55 interaction between 45 and the S2 region of neuraminidase ensures a high inhibition. However, this agent may not confer ideal therapeutic characteristics due to several side effects.
The establishment of a practical, efficient, and versatile synthetic route would contribute to further structure-activity 60 relationship (SAR) studies needed for the development of safe and potent neuraminidase inhibitors. 
Azomethine ylides

5
Azomethine ylides are 1,3-dipoles very frequently generated in situ, by a thermal 1,2-prototropy shift in iminoesters 50 or by a base-assisted formation of a metallo-dipole also from 50. Although many other methods are known, the metallo-dipole 10 route is the most employed due to its simplicity and the mildness of the reaction conditions required. 7, 62 According to the stereochemical point of view, metallo-dipoles 52 are crucial species because its geometry is perfectly controlled, which allows to obtain highly diastereoselective 1,5-cis- 15 adducts. The frontier orbital theory (FOT) explains the high regioselectivity and very important endo/exo diastereoselections achieved in the preparation of proline derivatives 53 63 (Scheme 7), following the identical dipoledipolarophile approach depicted for nitrones (see Scheme 5).
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All this features are a solid support to catalytic enantioselective processes 64 determining unambiguously the absolute configuration of up to four stereogenic centres of pyrrolidines 53. 65 The 1,3-DC using azomethine ylides is only productive when electron-deficient alkenes are employed. being the most prevalent, followed by genotype 2 and 3. Inside of the infected hepatocyte, structural E1 and E2 and non-structural proteins such as NS2, NS3 (which bears serine proteinase, helicase, and NTPase activities), NS4A, NS4B, NS5A (regulators of RNA replication), and NS5B (the RNA-40 dependent RNA polymerase) are generated. 66, 67 So, their high replication rates (billions of copies per day) can be drastically suppressed by the inhibition of the NS5B RNA-dependent RNA polymerase enzyme, which is the primary target for oral antiviral agents 54− 57 ( Figure 9 ). supported Wang resin-azomethine ylides 58 and tert-butyl acrylate (Scheme 8). The pure enantiomers were separated by preparative chiral HPLC, after amidation and hydrolysis of both esters groups. 69 In this way, many N-acyl pyrrolidines were designed finding heterocyclic compound 57 as the most 5 promising candidate to help infected people. The potent activity of these series of products was correlated with the binding site identification and genotypic profiling of HCV polymerase inhibitors. 70 The search for hepatitis C virus polymerase inhibitors has resulted in the 10 discovery of several non-nucleoside binding pockets. The shape and nature of these binding sites differ across and even within diverse hepatitis C genotypes. These differences confront antiviral drug discovery with the challenge of binding compounds that are capable of inhibition in variable 15 binding pockets. It was demonstrated that the recombinant P495L, M423T, M414T, and S282T mutant enzymes could be used to identify the binding site of the acyl pyrrolidine inhibitors. For these prolines it was found that Phe415 is crucial for genotype 1a coverage. Hydrogen bonding and Scheme 8. Synthesis of the racemic endo-54 35 The first synthesis of racemic product 55, and another derivatives including compound 54 was achieved in several steps using as the key reaction the silver(I) or lithiummetalloazomethine ylide, generated from iminoester 60 under basic conditions and tert-butyl acrylate. The resulting 40 cycloadduct 61 was obtained in 67% yield through a nonconcerted mechanism (Scheme 9). The enantiomeric samples were isolated from semi-preparative chiral HPLC. A small modification on the side chain of the heterocycle (amido group instead of carboxylic group) gave raise to product 62, 45 which in its (+)-form exhibited superior activity in both the enzyme and the replicon assays (Scheme 9). Molecule 56 (3082) was obtained through the analogous key intermediate 61 (Scheme 9). These 3-methoxyarylamides had superior solubility properties and lower molecular weights than other precedent antiviral agents. In this occasion, to 55 resolve the racemic mixtures of compound 61, (R)-(−)-1,1'-binaphthyl-2,2'-diyl-hydrogen phosphate was employed providing the required diastereomeric salt in good yield and excellent enantiomeric excess at the end of the process (98.8%). In this work, a comparison of the X-ray structures of 60 dicarboxylic acid 55 and the binding site of the HCV polymerase was surveyed. The bulkier tert-butyl substituent on the benzamide caused movement in the side chain of Leu384 allowing inhibitors to bind deeper into the pocket an increase their antiviral power. 72 This result was in total 65 agreement with those previously reported (see above).
The first endo-diastereoselective 1,3-DC of the key precursors of these antiviral agents was achieved via silver(I)-metalloazomethine ylide in the presence of acrylates derived from (R)-or (S)-methyl lactate 64. The diastereoselection was 70 very high (96% de) and 77% of chemical yield. Enantiomerically enriched (+)-54 and (−)-54 forms were finally isolated in 96% ee and in 51-54% yield (overall yield from iminoester 63), after successive amidation and double hydrolytic process. In spite of the small size of the 75 substituents bonded around the stereogenic centre, it was demonstrated that the excellent stereocontrol was originated by the interaction of the lactate methyl groups and the phenyl residue of the starting iminoester. The more straightforward and faster approach to the 5 enantiomeric forms of these non-nucleosidic antiviral agents is based on a catalytic enantioselective 1,3-DC as the key step. 64 The asymmetric reaction was pioneered by Grigg and coworkers in 1991 using stoichimetric amounts of chiral bases or chiral metal complexes. 74 However, it was in 2002 just 10 when the first substoichiometric catalytic (3 mol%) enantioselective transformation was successfully reported by Zhang and coworkers using a chiral diphosphane/silver(I) complex. 75 At that time, this cycloaddition became a fascinating transformation and many contributions appeared 15 with outstanding results. Chiral metal complexes, chiral bases, and chiral organocatalysts have been tested obtaining the best results, in terms of diastereo-and enantioselectivities, and wider general scope when chiral metallodipoles were generated as intermediate products. Silver(I) 76 and copper (I)   77   20 catalytic complexes afforded the most efficient and attractive processes.
78,79
The first enantioselective synthesis of the five-membered core of these structures was performed by using a chiral phosphoramidite 67 and AgClO 4 (both in 5 mol% amounts) as 25 catalyst. The reaction run at −20 ºC furnishes a good yield of compound endo-66 with a high enantioselection (Scheme 11, and Table 1 , entry 1). In this work, the synthesis of enantiomerically enriched product 54 (82% ee) was also reported after amidation and double hydrolytic sequence 30 involving TFA/0 ºC followed by KOH-MeOH/80 ºC. 76j,80 Box ligand 68 and calcium isopropoxide formed a chiral complex, which was used to catalyse the process at −44 or −30 ºC in THF as solvent. The yields are high and the enantioselectivities are the highest reported to date for 35 compound 66 (85 and 88% ee) (Scheme 11 and Table 1 , entries 2 and 3). 78d Apart from the Lewis acid-catalysed 1,3-DC the concept of organocatalysis was applied to the synthesis of 66 using hydroquinine 69 as quiral base (6 mol%) together with a 3 mol% amount of silver acetate. Although 40 chemical yields were very important, the enantioselection was moderate (74% ee) (Scheme 11, and Table 1 , entry 4). In fact, a further 1,1'-binaphthyl-2,2'-dihydrogen phosphate asisted chiral resolution of 66 was performed in order to obtain pure compound endo-66 with a 99.8% ee. To the best of our knowledge the synthesis of antiviral agent 57 has not been reported yet, 81 and it appeared as a consequence of evolutive structural modifications of the 55 precedent inhibitors, namely potency of the molecule, cell penetration and pharmacokinetics. Product 57 (GSK625433) is the most potent and selective drug having a good pharmacokinetic profile in phases I and II. This last compound does not inhibit human DNA polymerases, can be 60 administrated in low concentrations and no significant cytotoxicity was observed. 82 The discovery of the active specific interaction site polymerase-receptor for the inhibitors supports this new trend of therapy. A small modification in the final structure of 57 can be translated in a more potent 65 inhibition of the named viral polymerase, the highest optical purity of intermediate 66 being modulated by selecting the most appropriate solvent, silver salt, chiral ligand, temperature, and base. This alternative therapy is orally administrated in smaller amounts, it is more inexpensive and causes much less side effects and complications than the current subcutaneous pegylated α-interferon treatment combined with oral ribavirin. In addition, RNA-polymerase inhibition is much more effective than the inhibition of other structural and non-5 structural viral proteins in the fight against HCV.
Nitrile oxides
10
Similarly to azomethine ylides, nitrile oxides 71 have to be generated in situ. There are many methods described for their preparation, 7d dehydrohalogenation of hydroxymoyl chlorides 70 and dehydration of nitroalkanes being the most frequently used strategies. The regioselectivity of the 1,3-DC of nitrile 15 oxides and alkenes or alkynes is easily predictable. For monosubstituted alkenes and electrophilic olefins major regioisomer isoxazoles or isoxazolines 48 72a and 72b are, respectively, isolated as pure compounds (Scheme 12). At maximum, only two stereogenic centres can be generated 20 employing catalytic enantioselective synthesis. 
25
As well as it was described previously for azides, nitrile oxides are used to strategically modify several parts of the molecule with the aim to increase its antiviral potency. Initial contributions were designed for studying the antiviral activity of a series of products, but any biological results of essays 30 was detailed. 83 That was the case of C-nucleoside analogues 73 84 , and isoxazolines 74 85 (Figure 10 ), which were obtained following the conditions depicted on Scheme 12 but using an α-bromoacrylic system. 86 The results were very promising against HIV, 78 (n = 1) being the most effective and less cytotoxic drug. 89 The connection of oxygen and nitrogen atoms provided a possibility to introduce 50 the nucleophilic nitrogen into the furanose ring with a minimum of steric manipulation, providing opportunities to modify the furanose ring of nucleoside analogues with novel structural features. Consequently, it became possible to design other related N,O-containing derivatives for biological 55 studies. However, homologue compounds 78 (n = 0) (Base = thymine, fluorouracil, or cytosine) and 79 (Base = thymine) ( Figure 10 ) completely inhibited the reverse transcriptase activity of the avian myeloblastosis retrovirus at 10 μM 60 concentration. These isoxazolines 78, and 79 exhibited lower potency with respect to isoxazolidine derivatives 40, and 41 ( Figure 8) . 90 The lesser ability to elicit recognition by the reverse transcriptase, due to the insertion of a double bond in the five-membered heterocycle, can be attributed to a lower 65 molecular flexibility and a lower basicity of the nitrogen atom. Such as it was already mentioned, the bivalent metallic ions assisted the insertion of nucleotides in the growing nucleic acid chain. In this particular case, Mg +2 could form a six-membered chelate with the nitrogen atom and the oxygen 70 of the phosphorous group as well.
90
The 1,3-DC involving nitrile oxides and alkynes (methyl propiolate) was studied in the generation of isoxazoles and isothiazoles 80 and 81, respectively. These aryl-substituted heteroaromatic carboxylic acids (when R = 3-BnO in 80, and 75 R = 4-NO 2 in 81) afforded advantageous features of improvement of antiviral potency against HIV-1 integrase and decreased cytotoxicity with high therapeutic index. The good antiviral potency of the heteroaromatic carboxylic acid series could be attributable to the improved bioavailability of the 80 bioisosteres. On the other hand, the inconsistency between integrase inhibitory activity and the antiviral effect might involved multiple targeting in the HIV-1 life cycle. 91 Finally, 2-deoxyuridine derivatives 82 (Figure 10 ), formed by 1,3-DC of nitrile oxides and 5-alkynyluridines showed a 85 poor affinity for HSV-1-specific thymidine kinase. 
Diazoalkanes and carbonyl ylides
5
For a long time diazo-compounds 83 have been one of the most synthetically useful classes of 1,3-dipoles because they could be prepared and isolated in pure form in contrast o another 1,3-dipoles that are generated as transient species.
7d 10 The cycloadditions with double or triple bonds (including heteroatoms) have been widely surveyed (Scheme 13). 7 The reaction with electrophilic olefins occurred such as it is depicted in Scheme 13, the carbon atom reacted at the 4-position of the electrophile with almost total selectivity to 15 yield pyrazoline or pyrazole derivatives 84 and 85, nevertheless, some mixtures are obtained by reaction with electron-rich alkenes. In addition, the reaction of diazoalkanes with nitriles also give good regioselectivities of the corresponding compounds 85 (Scheme 13). Diazo-compounds 98 were allowed to react with coumarins 97, bearing a nitrile functional group, yielding products 99 in 5 very good yields (73-85%). After several steps coumarins 100 and the analogous adducts 101 were isolated. Compounds 101 showed encouraging results by inhibition of HIV-1 with an IC 50 value >0.17 μM, whilst none of the tested compounds 100 was found to inhibit HIV-1 or HIV-2 replication. The 10 structure-activity relationship (SAR) suggested that molecules incorporating the carbon-coumarin linkage manifested a higher HIV inhibition activity than that of the corresponding analogues having the oxygen linkage as structures 100. 98 These results would lead to modify the target molecules by 15 the introduction of more potential groups with a carbon linkage. To the best of our knowledge only one example of compounds with antiviral activity was published employing a 1,3-DC between in situ generated carbonyl ylides and alkenes.
25
In this work tetrahydrofuranyl glycine 104 have been obtained in 65% yield from L-vinylglycine 102 through a 1,3-DC reaction using the non-stabilised carbonyl ylide, prepared from carcinogenic bis(chloromethyl) ether 103. The reaction was run at 0 ºC achieving better chemical yield of a 57:43 30 mixture of diastereoisomers (Scheme 18). 99 The resulting polypeptides, incorporating this α-amino acid 104, acted as substrate-based inhibitors of HIV-1 protease. The inhibitory action of these macromolecules was probably due to the favourable interactions at the S2 region of neuraminidase (see 35 above). This strategy proved to be very valuable to medicinal and peptide chemistry due to the numerous modifications to essay. 
Conclusions
45
After more than a century after their discovery, these 1,3-DCs represent a powerful tool in modern synthetic chemistry whose limits are still being explored. According to the previously described contents and in the search of drugs with the wider spectrum of activity, a clear perspective can be 50 defined: the 1,3-DCs allow structural simple modifications, which fits to Lipinki's rules, facilitating the interaction drugvirus at different stages. Ylides are easily generated, the reactions involved are highly regio-and diastereoselective, even with elevated enantioselection for enantioselective 55 processes. The reaction conditions are usually very mild and the atom economy is almost total. Azides, nitrones, and azomethine ylides are the most employed dipoles giving rise to nitrogenated five membered ring heterocycles. Particularly interesting is the enantioselective approach to them using 60 substoichiometric amounts of chiral catalysts.
The most promising methodology is based on the azomethine ylide and its reactions with alkenes. In fact, this cycloaddition is a light of hope for the more of 190 million people having chronical hepatitis C in the world. This 65 asymmetric reaction would allow to prepare multiple libraries of chiral molecules able to inhibit the HCV replication. The scope of these products can be also applied to the single or combined treatment of the HIV/HCV coinfected people (15 million of patients in a critical situation) or for the treatment 70 of influenza or other devastating viruses, however, we have not any data about all these ambitious goals.
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